Stock Track | Charles River Laboratories Soars 5.24% on Positive Analyst Views

Stock Track

Feb 24, 2025

Charles River Laboratories (CRL) stock soared 5.24% in Monday's intraday trading session. The rise appears to be driven by positive research updates from analysts covering the company.

According to TD Cowen, the firm cut its price target on CRL to $179 from $182 but maintained a Hold rating on the stock. The adjustment followed Charles River's recent financial results and likely factors in the analysts' updated outlook for the company.

Additionally, broader market sentiment towards Charles River Laboratories seems favorable, as evidenced by the news roundup highlighting various analysts raising their ratings and price targets on the stock. The positive analyst views suggest optimism around CRL's growth prospects and potential earnings performance.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1155495624"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1155495624\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1155495624?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-24 22:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1155495624","market":"us","top_or_hot":-1,"title":"Stock Track | Charles River Laboratories Soars 5.24% on Positive Analyst Views","media":"Stock Track","content":"<p>Charles River Laboratories (CRL) stock soared 5.24% in Monday's intraday trading session. The rise appears to be driven by positive research updates from analysts covering the company.</p>\n\n<p>According to TD Cowen, the firm cut its price target on CRL to $179 from $182 but maintained a Hold rating on the stock. The adjustment followed Charles River's recent financial results and likely factors in the analysts' updated outlook for the company.</p>\n\n<p>Additionally, broader market sentiment towards Charles River Laboratories seems favorable, as evidenced by the news roundup highlighting various analysts raising their ratings and price targets on the stock. The positive analyst views suggest optimism around CRL's growth prospects and potential earnings performance.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Charles River Laboratories Soars 5.24% on Positive Analyst Views</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Charles River Laboratories Soars 5.24% on Positive Analyst Views\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-24 22:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Charles River Laboratories (CRL) stock soared 5.24% in Monday's intraday trading session. The rise appears to be driven by positive research updates from analysts covering the company.</p>\n\n<p>According to TD Cowen, the firm cut its price target on CRL to $179 from $182 but maintained a Hold rating on the stock. The adjustment followed Charles River's recent financial results and likely factors in the analysts' updated outlook for the company.</p>\n\n<p>Additionally, broader market sentiment towards Charles River Laboratories seems favorable, as evidenced by the news roundup highlighting various analysts raising their ratings and price targets on the stock. The positive analyst views suggest optimism around CRL's growth prospects and potential earnings performance.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CRL","symbol_name":"查尔斯河","start_time":0,"source_url":"","article_id":"1155495624","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1155495624","pubTimestamp":1740407828,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Charles River Laboratories  stock soared 5.24% in Monday's intraday trading session. The rise appears to be driven by positive research updates from analysts covering the company.According to TD Cowen, the firm cut its price target on CRL to $179 from $182 but maintained a Hold rating on the stock. The adjustment followed Charles River's recent financial results and likely factors in the analysts' updated outlook for the company.Additionally, broader market sentiment towards Charles River Labora","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CRL":"查尔斯河"},"translate_title":"Charles River Laboratories股票因分析师积极观点而飙升5.24%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CRL":1},"content_text":"Charles River Laboratories (CRL) stock soared 5.24% in Monday's intraday trading session. The rise appears to be driven by positive research updates from analysts covering the company.\nAccording to TD Cowen, the firm cut its price target on CRL to $179 from $182 but maintained a Hold rating on the stock. The adjustment followed Charles River's recent financial results and likely factors in the analysts' updated outlook for the company.\nAdditionally, broader market sentiment towards Charles River Laboratories seems favorable, as evidenced by the news roundup highlighting various analysts raising their ratings and price targets on the stock. The positive analyst views suggest optimism around CRL's growth prospects and potential earnings performance.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}